보도자료 | Roquette Ventures invests in Advanced Protein Technologies
작성자관리자작성일 19-11-12 00:00
The companies signed an agreement to accelerate the Global Business of new promising human breast milk components for Food, Nutrition and Health markets
Roquette Ventures, an investment company supporting pioneer innovations for Food, Nutrition and Health markets, and Advanced Protein Technologies (AP Technologies), a bio venture company developing Human Milk Oligosaccharides (HMOs), cognitive and immune-activating ingredients that only exist in human milk, announced that they have signed an agreement to work together on the development of new promising human breast milk components.
Edouard Nuttin, General Manager of Roquette Ventures added “This investment represents an important collaboration for us. As long term strategic partner, we are driven by a strong desire to support pioneering innovations and to contribute to accelerating their development. AP Technologies has a great growth potential and we are very pleased to be part of this journey to better answer Food, Heatlh and Nutrition markets expectations worldwide. AP Technologies’ HMOs will definitily bring unique advantages and benefits to consumers.”
After establishing its position in the food and health industry, AP Technologies will embark on its long term plans of entering the cosmetic, nutraceuticals, pet food and pharmaceutical market with products that generate immune activation, brain development and synergistic effects of the gut microbiome.